Why is Astrazeneca Phar falling/rising?

As of 11-Jul, Astrazeneca Pharma India Ltd's stock price is rising, currently at 9,236.60, reflecting an increase of 113.9 or 1.25%. Today's performance indicates that the stock has outperformed its sector by 0.67%. It is trading higher than its 5-day, 50-day, 100-day, and 200-day moving averages, although it is lower than the 20-day moving average. Despite a recent decline in investor participation, with delivery volume falling by 10.85% against the 5-day average, the company has demonstrated strong financial performance, including a significant net profit growth of 88.82% and positive results over the last two quarters. However, the stock is considered expensive with a high Price to Book Value ratio of 32.4, and institutional investors have reduced their stake, indicating some caution in the market.
In the broader market context, Astrazeneca's stock has shown a positive year-to-date return of 25.93%, significantly outperforming the Sensex, which has only increased by 5.58% during the same period. In the short term, the stock has gained 1.70% over the past week while the Sensex has declined by 1.12%, further highlighting its relative strength. Despite these positive indicators, concerns about long-term growth and falling institutional participation may temper investor enthusiasm. Overall, while the stock is currently rising, the mixed signals regarding valuation and investor interest suggest a complex market sentiment.